These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 17944680

  • 1. Incidence of anaemia among HIV-infected patients treated with highly active antiretroviral therapy.
    Curkendall SM, Richardson JT, Emons MF, Fisher AE, Everhard F.
    HIV Med; 2007 Nov; 8(8):483-90. PubMed ID: 17944680
    [Abstract] [Full Text] [Related]

  • 2. High incidence of zidovudine induced anaemia in HIV infected patients in eastern India.
    Agarwal D, Chakravarty J, Chaube L, Rai M, Agrawal NR, Sundar S.
    Indian J Med Res; 2010 Oct; 132():386-9. PubMed ID: 20966515
    [Abstract] [Full Text] [Related]

  • 3. Haematological changes after switching from stavudine to zidovudine in HIV-infected children receiving highly active antiretroviral therapy.
    Aurpibul L, Puthanakit T, Sirisanthana T, Sirisanthana V.
    HIV Med; 2008 May; 9(5):317-21. PubMed ID: 18331562
    [Abstract] [Full Text] [Related]

  • 4. Prior antiretroviral therapy experience protects against zidovudine-related anaemia.
    Huffam SE, Srasuebkul P, Zhou J, Calmy A, Saphonn V, Kaldor JM, Ditangco R, TREAT Asia HIV Observational Database (TAHOD).
    HIV Med; 2007 Oct; 8(7):465-71. PubMed ID: 17760739
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of anemia and correlation with biomarkers and specific antiretroviral regimens in 9690 human-immunodeficiency-virus-infected patients: findings of the Anemia Prevalence Study.
    Mildvan D, Creagh T, Leitz G, Anemia Prevalence Study Group.
    Curr Med Res Opin; 2007 Feb; 23(2):343-55. PubMed ID: 17288689
    [Abstract] [Full Text] [Related]

  • 6. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
    Ekouevi DK, Coffie PA, Becquet R, Tonwe-Gold B, Horo A, Thiebaut R, Leroy V, Blanche S, Dabis F, Abrams EJ.
    AIDS; 2008 Sep 12; 22(14):1815-20. PubMed ID: 18753864
    [Abstract] [Full Text] [Related]

  • 7. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
    Taha TE, Kumwenda J, Cole SR, Hoover DR, Kafulafula G, Fowler MG, Thigpen MC, Li Q, Kumwenda NI, Mofenson L.
    J Infect Dis; 2009 Nov 15; 200(10):1490-7. PubMed ID: 19832114
    [Abstract] [Full Text] [Related]

  • 8. Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy.
    Polesel J, Clifford GM, Rickenbach M, Dal Maso L, Battegay M, Bouchardy C, Furrer H, Hasse B, Levi F, Probst-Hensch NM, Schmid P, Franceschi S, Swiss HIV Cohort Study.
    AIDS; 2008 Jan 11; 22(2):301-6. PubMed ID: 18097233
    [Abstract] [Full Text] [Related]

  • 9. Common occurrence of anaemia at the end of pregnancy following exposure to zidovudine-free regimens.
    Pinnetti C, Baroncelli S, Molinari A, Nardini G, Genovese O, Ricerca BM, Cavaliere AF, Guaraldi G, Antoni AD, Tamburrini E, Floridia M.
    J Infect; 2011 Aug 11; 63(2):144-50. PubMed ID: 21683094
    [Abstract] [Full Text] [Related]

  • 10. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors.
    Corral I, Quereda C, Moreno A, Pérez-Elías MJ, Dronda F, Casado JL, Muriel A, Masjuán J, Alonso-de-Leciñana M, Moreno S.
    Cerebrovasc Dis; 2009 Aug 11; 27(6):559-63. PubMed ID: 19390181
    [Abstract] [Full Text] [Related]

  • 11. Anaemia and zidovudine-containing antiretroviral therapy in paediatric antiretroviral programmes in the IeDEA Paediatric West African Database to evaluate AIDS.
    Renner LA, Dicko F, Kouéta F, Malateste K, Gueye RD, Aka E, Eboua TK, Azondékon A, Okomo U, Touré P, Ekouévi D, Leroy V, IeDEA West Africa Paediatric Collaboration.
    J Int AIDS Soc; 2013 Sep 17; 16(1):18024. PubMed ID: 24047928
    [Abstract] [Full Text] [Related]

  • 12. Effectiveness of antiretroviral treatment in a South African program: a cohort study.
    Fairall LR, Bachmann MO, Louwagie GM, van Vuuren C, Chikobvu P, Steyn D, Staniland GH, Timmerman V, Msimanga M, Seebregts CJ, Boulle A, Nhiwatiwa R, Bateman ED, Zwarenstein MF, Chapman RD.
    Arch Intern Med; 2008 Jan 14; 168(1):86-93. PubMed ID: 18195200
    [Abstract] [Full Text] [Related]

  • 13. Incidence and risk factors of nevirapine-associated severe hepatitis among HIV-infected patients with CD4 cell counts less than 250 cells/microL.
    Manosuthi W, Sungkanuparph S, Tansuphaswadikul S, Chottanapund S, Mankatitham W, Chimsuntorn S, Sittibusaya C, Moolasart V, Chaovavanich A.
    J Med Assoc Thai; 2008 Feb 14; 91(2):159-65. PubMed ID: 18389979
    [Abstract] [Full Text] [Related]

  • 14. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
    Patel K, Hernán MA, Williams PL, Seeger JD, McIntosh K, Van Dyke RB, Seage GR, Pediatric AIDS Clinical Trials Group 219/219C Study Team.
    Clin Infect Dis; 2008 Feb 15; 46(4):507-15. PubMed ID: 18199042
    [Abstract] [Full Text] [Related]

  • 15. Safety of zidovudine dose reduction in treatment-naïve HIV infected patients. A randomized controlled study (MiniZID).
    Rougemont M, Nchotu Ngang P, Stoll B, Delhumeau C, Hill A, Ciaffi L, Bonnet F, Menga G, Fampou JC, Calmy A.
    HIV Med; 2016 Mar 15; 17(3):206-15. PubMed ID: 26354678
    [Abstract] [Full Text] [Related]

  • 16. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
    Ortega KL, Vale DA, Magalhães MH.
    J Oral Pathol Med; 2009 Jul 15; 38(6):489-94. PubMed ID: 19453845
    [Abstract] [Full Text] [Related]

  • 17. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
    Coffie PA, Ekouevi DK, Chaix ML, Tonwe-Gold B, Clarisse AB, Becquet R, Viho I, N'dri-Yoman T, Leroy V, Abrams EJ, Rouzioux C, Dabis F.
    Clin Infect Dis; 2008 Feb 15; 46(4):611-21. PubMed ID: 18197758
    [Abstract] [Full Text] [Related]

  • 18. Risk of recurrent nontyphoid Salmonella bacteremia in HIV-infected patients in the era of highly active antiretroviral therapy and an increasing trend of fluoroquinolone resistance.
    Hung CC, Hung MN, Hsueh PR, Chang SY, Chen MY, Hsieh SM, Sheng WH, Sun HY, Huang YT, Lo YC, Hsiao CF, Chang SC.
    Clin Infect Dis; 2007 Sep 01; 45(5):e60-7. PubMed ID: 17682981
    [Abstract] [Full Text] [Related]

  • 19. A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South Africa.
    Bolhaar MG, Karstaedt AS.
    Clin Infect Dis; 2007 Jul 15; 45(2):254-60. PubMed ID: 17578788
    [Abstract] [Full Text] [Related]

  • 20. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection.
    Powles T, Robinson D, Stebbing J, Shamash J, Nelson M, Gazzard B, Mandelia S, Møller H, Bower M.
    J Clin Oncol; 2009 Feb 20; 27(6):884-90. PubMed ID: 19114688
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.